These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23345952)

  • 1. Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.
    Jun CH; Ki HS; Lee HK; Park KJ; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    World J Gastroenterol; 2013 Jan; 19(2):284-9. PubMed ID: 23345952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE.
    Jun CH; Ki HS; Lee KH; Park KJ; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Clin Mol Hepatol; 2013 Mar; 19(1):70-7. PubMed ID: 23593612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
    Favelier S; Boulin M; Hamza S; Cercueil JP; Cherblanc V; Lepage C; Hillon P; Chauffert B; Krausé D; Guiu B
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1039-46. PubMed ID: 23224215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
    Li J; Shi C; Shi J; Song J; Wang N
    Medicine (Baltimore); 2021 Nov; 100(44):e27636. PubMed ID: 34871232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.
    Kim DS; Lim TS; Jeon MY; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Baatarkhuu O; Kim SU
    Dig Dis Sci; 2019 Dec; 64(12):3660-3668. PubMed ID: 31187326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma?
    Shim JH; Park JW; Choi JI; Kim HB; Lee WJ; Kim CM
    J Vasc Interv Radiol; 2009 Feb; 20(2):209-16. PubMed ID: 19084432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K; Arii S; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M
    J Hepatol; 2012 Apr; 56(4):886-92. PubMed ID: 22173160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
    Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
    AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.
    Luo J; Peng ZW; Guo RP; Zhang YQ; Li JQ; Chen MS; Shi M
    Radiology; 2011 Apr; 259(1):286-95. PubMed ID: 21330557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
    Yang Z; Zou R; Zheng Y; Qiu J; Shen J; Liao Y; Zhang Y; Wang C; Wang Y; Yuan Y; Li K; Zuo D; He W; Liu W; Li B; Yuan Y
    Eur Radiol; 2019 Nov; 29(11):5752-5762. PubMed ID: 30993438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?].
    Huppert PE; Lauchart W; Duda SH; Torkler C; Kloska SP; Weinlich M; Benda N; Pereira P; Claussen CD
    Rofo; 2004 Mar; 176(3):375-85. PubMed ID: 15026951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
    Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma.
    Huang D; Chen Y; Chen S; Zeng Q; Zhao J; Wu R; Li Y
    Medicine (Baltimore); 2017 Jul; 96(30):e7650. PubMed ID: 28746230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
    Li CP; Chao Y; Chen LT; Lee RC; Lee WP; Yuan JN; Yen SH; Lee SD
    Scand J Gastroenterol; 2008 Aug; 43(8):992-9. PubMed ID: 19086281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.